The planned free float is deliberately small—roughly 2–3% of SK Hynix’s total outstanding shares . But thanks to a market capitalization that recently surged past $1 trillion, even that thin slice translates to approximately $9.6 billion to $14.4 billion in potential proceeds
. Early South Korean media reports pegged the target lower, at 10 trillion to 15 trillion won (about $6.7–$10 billion), but more recent estimates from sources have skewed toward the upper end of the range
. Regardless of where the final number lands, the transaction is on track to rank among the largest-ever US listings by a foreign issuer
.
Three interlocking tailwinds are propelling the listing:
“Financial strength is essential to continue investment and growth,” Kwak told shareholders earlier this year, framing the ADR as a strategic move rather than a luxury .
The proceeds are already spoken for, earmarked for colossal manufacturing projects on two continents. In Yongin, South Korea, the company approved a KRW 21.6 trillion (roughly $15 billion) investment to construct new semiconductor fabrication facilities by the end of 2030 . Meanwhile, in the US, SK Hynix broke ground in April 2026 on a $3.87 billion advanced packaging plant in West Lafayette, Indiana
. The broader capital plan includes a record $8 billion order for ASML extreme ultraviolet (EUV) lithography machines, signaling ambitions far beyond just one product cycle
.
For all the headline-grabbing numbers, SK Hynix has remained conspicuously cautious in its public statements. The F-1 filing itself contains the standard disclaimer that “specific details—such as the size, structure, and timeline of the offering—have not yet been finalized .” The company emphasizes that the listing is subject to US regulatory approval and market conditions, and that the eventual size will hinge on real-time investor demand when shares are priced
. As of mid-June 2026, the final offering terms remain fluid, even as the infrastructure buildout—and the AI memory demand powering it—continues at full tilt.
Comments
0 comments